TIAM1 and hepatocellular carcinoma: However, inducible approaches, such as the recently reported Cre-Controlled CRISPR mutagenesis [20], could be employed to more clearly determine if loss of TIAM1 expression is specifically toxic to HCC subgroup-2 cells.